Design, synthesis, and neuroprotective effects of a dimeric dipeptide mimetic of the third loop of the nerve growth factor


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Previously, we prepared dimeric dipeptide mimetics of the first and the fourth loops of the nerve growth factor (NGF): hexamethylenediamides of bis(N-aminocaproyl-glycyl-L-lysine) (GK-6) and bis(N-monosuccinyl-L-glutamyl-L-lysine) (GK-2). Both mimetics activated TrkA-receptors, but induced different postreceptor signal pathways. GK-2 selectively activated PI3K/AKT, whereas GK-6 activated both PI3K/AKT and MAPK/ERK. Both mimetics exhibited a neuroprotective activity. In this study, we continued the investigation of a contribution of separate loop-like structures in the NGF functions and created and studied dimeric dipeptide mimetics based on a beta-turn of the NGF third loop: hexamethylenediamides of bis(N-gamma-hydroxybutyryl-L-lysyl-L-histidine) (GTS-115) and bis(N-acetyl-L-lysyl-L-histidine) (GTS-113). GTS-115 was shown to exhibit the neuroprotective activity in the concentration range from 10–5 to 10–7 М towards the HT-22 cell culture under the conditions of oxidative stress. The acetyl-containing GTS-113 mimetic proved to be inactive. GTS-115 (1 mg/kg/day intraperitoneally, for 7 days, the administration was started 4 h after the operation) exhibited the neuroprotective properties and decreased the infarction volume by 25% on the model of a stroke that was induced by a transient occlusion of the medial cerebral artery of rats. The action mechanism of GTS-115 was studied by Western-blot analysis and this mimetic in a concentration of 10–6 М was shown to activate the TrkA-receptor and both MAPK/ERK and PI3K/AKT basic postreceptor signal pathways. The inhibitory analysis revealed different contributions of these pathways into the GTS-115 neuroprotective effect. The LY294002 selective inhibitor of PI3K completely blocked the neuroprotective effect of GTS-115 in vitro, whereas the PD98059 specific inhibitor of MEK1 and MEK2 decreased this effect only by 10–15%. GTS-115 peptide stimulated a differentiation of the PC12 cells and caused a hyperalgesia in rats. These facts were in a good agreement with the literature data on the participation of the MAP-kinase pathway in these effects. Thus, the third NGF loop and the neighboring first NGF loop activated the postreceptor pathways in a similar way and exhibited the similar activities.

Sobre autores

T. Gudasheva

Zakusov Research Institute of Pharmacology

Autor responsável pela correspondência
Email: tata-sosnovka@mail.ru
Rússia, Moscow, 125315

A. Tarasiuk

Zakusov Research Institute of Pharmacology

Email: tata-sosnovka@mail.ru
Rússia, Moscow, 125315

N. Sazonova

Zakusov Research Institute of Pharmacology

Email: tata-sosnovka@mail.ru
Rússia, Moscow, 125315

S. Pomogaibo

Zakusov Research Institute of Pharmacology

Email: tata-sosnovka@mail.ru
Rússia, Moscow, 125315

A. Shumskiy

Zakusov Research Institute of Pharmacology

Email: tata-sosnovka@mail.ru
Rússia, Moscow, 125315

I. Logvinov

Zakusov Research Institute of Pharmacology

Email: tata-sosnovka@mail.ru
Rússia, Moscow, 125315

S. Nikolaev

Zakusov Research Institute of Pharmacology

Email: tata-sosnovka@mail.ru
Rússia, Moscow, 125315

P. Povarnina

Zakusov Research Institute of Pharmacology

Email: tata-sosnovka@mail.ru
Rússia, Moscow, 125315

M. Konstantinopolsky

Zakusov Research Institute of Pharmacology

Email: tata-sosnovka@mail.ru
Rússia, Moscow, 125315

T. Antipova

Zakusov Research Institute of Pharmacology

Email: tata-sosnovka@mail.ru
Rússia, Moscow, 125315

S. Seredenin

Zakusov Research Institute of Pharmacology

Email: tata-sosnovka@mail.ru
Rússia, Moscow, 125315

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Pleiades Publishing, Ltd., 2017